Danhong Injection in the Treatment of Unstable Angina Pectoris

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT02007187

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02007187
Other papers using this trial's data
  • Efficacy of add-on Danhong injection in patients with unstable angina pectoris: A double-blind, randomized, placebo-controlled, multicenter clinical trial Journal of ethnopharmacology, 2022-02-10 DOI, PubMed 34732357

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02007187. Randomized; quadruple masking; primary purpose treatment. Start 2013-12 (actual); primary completion 2017-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Danhong Injection in the Treatment of Unstable Angina Pectoris
Condition
Unstable Angina Pectoris
Intervention (Drug)
Danhong injection
Intervention (Other)
Standard medical care
Intervention (Drug)
Placebo
Lead sponsor
China Academy of Chinese Medical Sciences (class: other)
Collaborator
China Food and Drug Administration (class: other government)

Record details

Record id
cardio:ct-nct02007187
Content hash
9ea63e5b18ba9ea3fe7b1f9dc78f3079e3b0fea8302aed37d194e7051151a02d